UBS Group’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.24B | Buy |
11,504,665
+2,224,498
| +24% | +$239M | 0.21% | 66 |
|
2025
Q1 | $936M | Buy |
9,280,167
+16,536
| +0.2% | +$1.67M | 0.17% | 84 |
|
2024
Q4 | $827M | Buy |
9,263,631
+1,491,819
| +19% | +$133M | 0.15% | 105 |
|
2024
Q3 | $651M | Buy |
7,771,812
+631,888
| +9% | +$53M | 0.14% | 106 |
|
2024
Q2 | $550M | Sell |
7,139,924
-638,461
| -8% | -$49.2M | 0.14% | 115 |
|
2024
Q1 | $533M | Buy |
7,778,385
+726,746
| +10% | +$49.8M | 0.13% | 121 |
|
2023
Q4 | $408M | Buy |
7,051,639
+1,531,625
| +28% | +$88.5M | 0.12% | 133 |
|
2023
Q3 | $291M | Sell |
5,520,014
-197,537
| -3% | -$10.4M | 0.1% | 162 |
|
2023
Q2 | $309M | Buy |
5,717,551
+43,643
| +0.8% | +$2.36M | 0.1% | 159 |
|
2023
Q1 | $284M | Sell |
5,673,908
-251,847
| -4% | -$12.6M | 0.1% | 169 |
|
2022
Q4 | $274M | Buy |
5,925,755
+756,716
| +15% | +$35M | 0.1% | 170 |
|
2022
Q3 | $200M | Sell |
5,169,039
-334,078
| -6% | -$12.9M | 0.09% | 187 |
|
2022
Q2 | $205M | Sell |
5,503,117
-12,903
| -0.2% | -$481K | 0.08% | 208 |
|
2022
Q1 | $244M | Buy |
5,516,020
+205,393
| +4% | +$9.1M | 0.08% | 196 |
|
2021
Q4 | $226M | Buy |
5,310,627
+548,414
| +12% | +$23.3M | 0.06% | 217 |
|
2021
Q3 | $207M | Buy |
4,762,213
+488,690
| +11% | +$21.2M | 0.07% | 223 |
|
2021
Q2 | $183M | Buy |
4,273,523
+897,913
| +27% | +$38.4M | 0.06% | 251 |
|
2021
Q1 | $130M | Buy |
3,375,610
+1,995,916
| +145% | +$77.1M | 0.04% | 315 |
|
2020
Q4 | $49.6M | Sell |
1,379,694
-226,933
| -14% | -$8.16M | 0.02% | 593 |
|
2020
Q3 | $61.4M | Sell |
1,606,627
-290,837
| -15% | -$11.1M | 0.02% | 448 |
|
2020
Q2 | $66.6M | Buy |
1,897,464
+396,890
| +26% | +$13.9M | 0.03% | 384 |
|
2020
Q1 | $49M | Sell |
1,500,574
-561,849
| -27% | -$18.3M | 0.02% | 424 |
|
2019
Q4 | $93.3M | Sell |
2,062,423
-322,119
| -14% | -$14.6M | 0.03% | 371 |
|
2019
Q3 | $97M | Buy |
2,384,542
+80,524
| +3% | +$3.28M | 0.04% | 336 |
|
2019
Q2 | $99M | Sell |
2,304,018
-96,278
| -4% | -$4.14M | 0.04% | 334 |
|
2019
Q1 | $92.1M | Buy |
2,400,296
+440,812
| +22% | +$16.9M | 0.04% | 340 |
|
2018
Q4 | $69.2M | Sell |
1,959,484
-200,690
| -9% | -$7.09M | 0.03% | 366 |
|
2018
Q3 | $83.2M | Buy |
2,160,174
+287,614
| +15% | +$11.1M | 0.03% | 373 |
|
2018
Q2 | $61.2M | Buy |
1,872,560
+787,397
| +73% | +$25.7M | 0.03% | 440 |
|
2018
Q1 | $29.6M | Sell |
1,085,163
-25,307
| -2% | -$691K | 0.01% | 709 |
|
2017
Q4 | $27.5M | Sell |
1,110,470
-300,329
| -21% | -$7.45M | 0.01% | 744 |
|
2017
Q3 | $41.2M | Sell |
1,410,799
-179,440
| -11% | -$5.23M | 0.02% | 538 |
|
2017
Q2 | $44.1M | Buy |
1,590,239
+237,094
| +18% | +$6.57M | 0.02% | 487 |
|
2017
Q1 | $33.7M | Buy |
1,353,145
+192,357
| +17% | +$4.78M | 0.02% | 573 |
|
2016
Q4 | $25.1M | Sell |
1,160,788
-115,641
| -9% | -$2.5M | 0.01% | 665 |
|
2016
Q3 | $30.4M | Buy |
1,276,429
+498,061
| +64% | +$11.9M | 0.02% | 563 |
|
2016
Q2 | $18.2M | Buy |
778,368
+158,325
| +26% | +$3.7M | 0.01% | 759 |
|
2016
Q1 | $11.7M | Sell |
620,043
-441,584
| -42% | -$8.31M | 0.01% | 957 |
|
2015
Q4 | $19.6M | Buy |
1,061,627
+300,642
| +40% | +$5.54M | 0.01% | 748 |
|
2015
Q3 | $12.5M | Sell |
760,985
-71,503
| -9% | -$1.17M | 0.01% | 939 |
|
2015
Q2 | $14.7M | Sell |
832,488
-28,830
| -3% | -$510K | 0.01% | 925 |
|
2015
Q1 | $15.3M | Sell |
861,318
-251,310
| -23% | -$4.46M | 0.01% | 914 |
|
2014
Q4 | $14.7M | Buy |
+1,112,628
| New | +$14.7M | 0.01% | 931 |
|